{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:50:40Z","timestamp":1768837840951,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002954","name":"Universit\u00e0 degli Studi di Milano-Bicocca","doi-asserted-by":"publisher","award":["FAR"],"award-info":[{"award-number":["FAR"]}],"id":[{"id":"10.13039\/501100002954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002954","name":"Universit\u00e0 degli Studi di Milano-Bicocca","doi-asserted-by":"publisher","award":["FAR"],"award-info":[{"award-number":["FAR"]}],"id":[{"id":"10.13039\/501100002954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12020-016-1184-2","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T11:01:03Z","timestamp":1480330863000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia"],"prefix":"10.1007","volume":"58","author":[{"given":"Elena","family":"Bresciani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Ravelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Liantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khoubaib","family":"Ben Haj Salah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Alain","family":"Fehrentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Omeljaniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4557-676X","authenticated-orcid":false,"given":"Antonio","family":"Torsello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","volume":"89","author":"MJ Tisdale","year":"1997","unstructured":"M.J. Tisdale, Biology of cachexia. J. Natl. Cancer Inst. 89, 1763\u20131773 (1997)","journal-title":"J. Natl. Cancer Inst."},{"key":"1184_CR2","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00467-006-0194-3","volume":"21","author":"RH Mak","year":"2006","unstructured":"R.H. Mak, W. Cheung, Energy homeostasis and cachexia in chronic kidney disease. Pediatr. Nephrol. 21, 1807\u20131814 (2006)","journal-title":"Pediatr. Nephrol."},{"issue":"Suppl 1","key":"1184_CR3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0954-6111(08)70005-2","volume":"102","author":"BR Celli","year":"2008","unstructured":"B.R. Celli, C.G. Cote, S.C. Lareau, P.M. Meek, Predictors of Survival in COPD: more than just the FEV1. Respir. Med. 102(Suppl 1), S27\u2013S35 (2008)","journal-title":"Respir. Med."},{"key":"1184_CR4","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0959-8049(02)00674-3","volume":"39","author":"PJ Hesketh","year":"2003","unstructured":"P.J. Hesketh, S. Van Belle, M. Aapro, F.D. Tattersall, R.J. Naylor, R. Hargreaves et al., Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur. J. Cancer 39, 1074\u20131080 (2003)","journal-title":"Eur. J. Cancer"},{"key":"1184_CR5","first-page":"14","volume":"19","author":"JD Hainsworth","year":"1992","unstructured":"J.D. Hainsworth, P.J. Hesketh, Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results. Semin. Oncol. 19, 14\u201319 (1992)","journal-title":"Semin. Oncol."},{"key":"1184_CR6","doi-asserted-by":"crossref","first-page":"1143S","DOI":"10.3945\/ajcn.2010.28608E","volume":"91","author":"NP Gullett","year":"2010","unstructured":"N.P. Gullett, G. Hebbar, T.R. Ziegler, Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting. Am. J. Clin. Nutr. 91, 1143S\u20131147S (2010)","journal-title":"Am. J. Clin. Nutr."},{"key":"1184_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00520-009-0722-3","volume":"18","author":"G Mantovani","year":"2010","unstructured":"G. Mantovani, C. Madeddu, Cancer cachexia: medical management. Support Care Cancer 18, 1\u20139 (2010)","journal-title":"Support Care Cancer"},{"key":"1184_CR8","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","volume":"86","author":"AM Wren","year":"2001","unstructured":"A.M. Wren, L.J. Seal, M.A. Cohen, A.E. Brynes, G.S. Frost, K.G. Murphy et al., Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1184_CR9","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/diabetes.50.11.2540","volume":"50","author":"AM Wren","year":"2001","unstructured":"A.M. Wren, C.J. Small, C.R. Abbott, W.S. Dhillo, L.J. Seal, M.A. Cohen et al., Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540\u20132547 (2001)","journal-title":"Diabetes"},{"key":"1184_CR10","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","volume":"87","author":"S Gnanapavan","year":"2002","unstructured":"S. Gnanapavan, B. Kola, S.A. Bustin, D.G. Morris, P. McGee, P. Fairclough et al., The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87, 2988 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1184_CR11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00280-005-0179-0","volume":"58","author":"YL Liu","year":"2006","unstructured":"Y.L. Liu, N.M. Malik, G.J. Sanger, P.L. Andrews, Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Cancer Chemother. Pharmacol. 58, 326\u2013333 (2006)","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1184_CR12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/en.2007-0828","volume":"149","author":"JM Garcia","year":"2008","unstructured":"J.M. Garcia, J.P. Cata, P.M. Dougherty, R.G. Smith, Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia. Endocrinology 149, 455\u2013460 (2008)","journal-title":"Endocrinology"},{"key":"1184_CR13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","volume":"6","author":"JA Chen","year":"2015","unstructured":"J.A. Chen, A. Splenser, B. Guillory, J. Luo, M. Mendiratta, B. Belinova et al., Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved. J. Cachexia Sarcopenia Muscle 6, 132\u2013143 (2015)","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1184_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000054601","volume":"72","author":"A Torsello","year":"2000","unstructured":"A. Torsello, V. Locatelli, M.R. Melis, S. Succu, M.S. Spano, R. Deghenghi et al., Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes. Neuroendocrinology 72, 327\u2013332 (2000)","journal-title":"Neuroendocrinology"},{"key":"1184_CR15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1530\/eje.0.1350481","volume":"135","author":"A Torsello","year":"1996","unstructured":"A. Torsello, R. Grilli, M. Luoni, M. Guidi, M.C. Ghigo, W.B. Wehrenberg et al., Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat. Eur. J. Endocrinol. 135, 481\u2013488 (1996)","journal-title":"Eur. J. Endocrinol."},{"key":"1184_CR16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0024-3205(94)00510-9","volume":"54","author":"R Deghenghi","year":"1994","unstructured":"R. Deghenghi, M.M. Cananzi, A. Torsello, C. Battisti, E.E. Muller, V. Locatelli, GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci. 54, 1321\u20131328 (1994)","journal-title":"Life Sci."},{"key":"1184_CR17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF03345618","volume":"31","author":"E Bresciani","year":"2008","unstructured":"E. Bresciani, N. Pitsikas, L. Tamiazzo, M. Luoni, I. Bulgarelli, D. Cocchi et al., Feeding behavior during long-term hexarelin administration in young and old rats. J. Endocrinol. Invest. 31, 647\u2013652 (2008)","journal-title":"J. Endocrinol. Invest."},{"key":"1184_CR18","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1021\/jm0704550","volume":"50","author":"A Moulin","year":"2007","unstructured":"A. Moulin, L. Demange, G. Berge, D. Gagne, J. Ryan, D. Mousseaux et al., Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. J. Med. Chem. 50, 5790\u20135806 (2007)","journal-title":"J. Med. Chem."},{"key":"1184_CR19","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1021\/jm070024h","volume":"50","author":"L Demange","year":"2007","unstructured":"L. Demange, D. Boeglin, A. Moulin, D. Mousseaux, J. Ryan, G. Berge et al., Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor 1. J. Med. Chem. 50, 1939\u20131957 (2007)","journal-title":"J. Med. Chem."},{"key":"1184_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbamem.2012.10.023","volume":"1828","author":"V Cassina","year":"2013","unstructured":"V. Cassina, A. Torsello, A. Tempestini, D. Salerno, D. Brogioli, L. Tamiazzo et al., Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity. Biochim. Biophys. Acta 1828, 455\u2013460 (2013)","journal-title":"Biochim. Biophys. Acta"},{"key":"1184_CR21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1210\/endo-122-3-855","volume":"122","author":"SG Cella","year":"1988","unstructured":"S.G. Cella, V. Locatelli, V. De Gennaro, G.P. Bondiolotti, C. Pintor, S. Loche et al., Epinephrine mediates the growth hormone-releasing effect of galanin in infant rats. Endocrinology 122, 855\u2013859 (1988)","journal-title":"Endocrinology"},{"key":"1184_CR22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0006-291X(86)80413-2","volume":"138","author":"MG Cozzi","year":"1986","unstructured":"M.G. Cozzi, A. Zanini, V. Locatelli, S.G. Cella, E.E. Muller, Growth hormone-releasing hormone and clonidine stimulate biosynthesis of growth hormone in neonatal pituitaries. Biochem. Biophys. Res. Commun. 138, 1223\u20131230 (1986)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1184_CR23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/endo-116-2-574","volume":"116","author":"SG Cella","year":"1985","unstructured":"S.G. Cella, V. Locatelli, V. de Gennaro, R. Puggioni, C. Pintor, E.E. Muller, Human pancreatic growth hormone (GH)-releasing hormone stimulates GH synthesis and release in infant rats. An in vivo study. Endocrinology 116, 574\u2013577 (1985)","journal-title":"Endocrinology"},{"key":"1184_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-007-0597-2","volume":"62","author":"DT Dickey","year":"2008","unstructured":"D.T. Dickey, L.L. Muldoon, N.D. Doolittle, D.R. Peterson, D.F. Kraemer, E.A. Neuwelt, Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models. Cancer Chemother. Pharmacol. 62, 235\u2013241 (2008)","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1184_CR25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3322\/canjclin.52.2.72","volume":"52","author":"A Inui","year":"2002","unstructured":"A. Inui, Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J. Clin. 52, 72\u201391 (2002)","journal-title":"CA Cancer J. Clin."},{"key":"1184_CR26","first-page":"139","volume":"18","author":"JSSM Damrauer","year":"2008","unstructured":"J.S.S.M. Damrauer, S. Acharyya, A.S. Baldwin, M.E. Couch, D.C. Guttridge, Chemotherapy-induced muscle wasting: association with NF-kB and cancer cachexia. Basic Appl. Myol. 18, 139\u2013148 (2008)","journal-title":"Basic Appl. Myol."},{"key":"1184_CR27","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","volume":"148","author":"MD DeBoer","year":"2007","unstructured":"M.D. DeBoer, X.X. Zhu, P. Levasseur, M.M. Meguid, S. Suzuki, A. Inui et al., Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 148, 3004\u20133012 (2007)","journal-title":"Endocrinology"},{"key":"1184_CR28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/en.2007-1046","volume":"149","author":"MD Deboer","year":"2008","unstructured":"M.D. Deboer, X. Zhu, P.R. Levasseur, A. Inui, Z. Hu, G. Han et al., Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 149, 827\u2013835 (2008)","journal-title":"Endocrinology"},{"key":"1184_CR29","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.3748\/wjg.14.6303","volume":"14","author":"S Perboni","year":"2008","unstructured":"S. Perboni, C. Bowers, S. Kojima, A. Asakawa, A. Inui, Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice. World J. Gastroenterol. 14, 6303\u20136305 (2008)","journal-title":"World J. Gastroenterol."},{"key":"1184_CR30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.lfs.2007.11.019","volume":"82","author":"D Yamamoto","year":"2008","unstructured":"D. Yamamoto, N. Ikeshita, T. Matsubara, H. Tasaki, E.H. Herningtyas, K. Toda et al., GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1. Life Sci. 82, 460\u2013466 (2008)","journal-title":"Life Sci."},{"key":"1184_CR31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nut.2009.07.003","volume":"26","author":"MD DeBoer","year":"2010","unstructured":"M.D. DeBoer, Update on melanocortin interventions for cachexia: progress toward clinical application. Nutrition 26, 146\u2013151 (2010)","journal-title":"Nutrition"},{"key":"1184_CR32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2004.07.066","volume":"498","author":"G Muccioli","year":"2004","unstructured":"G. Muccioli, N. Pons, C. Ghe, F. Catapano, R. Granata, E. Ghigo, Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur. J. Pharmacol. 498, 27\u201335 (2004)","journal-title":"Eur. J. Pharmacol."},{"key":"1184_CR33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/en.2003-0899","volume":"145","author":"NM Thompson","year":"2004","unstructured":"N.M. Thompson, D.A. Gill, R. Davies, N. Loveridge, P.A. Houston, I.C. Robinson et al., Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145, 234\u2013242 (2004)","journal-title":"Endocrinology"},{"key":"1184_CR34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.regpep.2012.06.003","volume":"178","author":"M Sugiyama","year":"2012","unstructured":"M. Sugiyama, A. Yamaki, M. Furuya, N. Inomata, Y. Minamitake, K. Ohsuye et al., Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice. Regul. Pept. 178, 21\u201328 (2012)","journal-title":"Regul. Pept."},{"key":"1184_CR35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1530\/eje.0.1390395","volume":"139","author":"EA Nijland","year":"1998","unstructured":"E.A. Nijland, C.J. Strasburger, C. Popp-Snijders, P.S. van der Wal, E.A. van der Veen, A five day treatment with daily subcutaneous injections of growth hormone-releasing peptide-2 causes response attenuation and does not stimulate insulin-like growth factor-I secretion in healthy young men. Eur. J. Endocrinol. 139, 395\u2013401 (1998)","journal-title":"Eur. J. Endocrinol."},{"key":"1184_CR36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/endo.143.2.8633","volume":"143","author":"M Tschop","year":"2002","unstructured":"M. Tschop, M.A. Statnick, T.M. Suter, M.L. Heiman, GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein. Endocrinology 143, 558\u2013568 (2002)","journal-title":"Endocrinology"},{"key":"1184_CR37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MCO.0b013e328339fdd2","volume":"13","author":"K Burckart","year":"2010","unstructured":"K. Burckart, S. Beca, R.J. Urban, M. Sheffield-Moore, Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies. Curr. Opin. Clin. Nutr. Metab. Care 13, 410\u2013416 (2010)","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"1184_CR38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"J.S. Temel, A.P. Abernethy, D.C. Currow, J. Friend, E.M. Duus, Y. Yan et al., Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 17, 519\u2013531 (2016)","journal-title":"Lancet Oncol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1184-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T11:23:06Z","timestamp":1505992986000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1184-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1184-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}